Senior insider sale
EVP and Chief Medical Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$49.5K
5.59K shares
What this filing means
EISNER MARK plans to sell 5.59K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $49.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/25/2026ACC: 0001959173-26-001456
Officer· EVP and Chief Medical Officer
Since Feb 2026
5.59K
Shares to sell
$49.5K
Approx. market value
1.89K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/23/2026
1.89KTotal acquired1.89K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2026 | Restricted Stock Vesting Compensation | 1.89K | — |
| Total | 1.89K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.62K
Market value
$15.4K
2/24/2026
—Completed
Units to sell
2.09K
Market value
$15.6K
2/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.89K
Market value
$18.5K
2/25/2026
Total
Units
5.59K
Value
$49.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/24/2026 | 1.62K | $15.4K | — | Completed |
2/23/2026 | 2.09K | $15.6K | — | Completed |
| Planned — Approximate Date | ||||
2/25/2026 | 1.89K | $18.5K | NASDAQ | Planned |
| Total | 5.59K | $49.5K | ||